SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $16,000 | 0.0% | 17,085 | +23.8% | 0.00% | – |
Q1 2022 | $16,000 | -81.6% | 13,804 | -48.1% | 0.00% | – |
Q4 2021 | $87,000 | -84.8% | 26,603 | -79.2% | 0.00% | – |
Q3 2021 | $571,000 | -24.2% | 127,710 | -7.5% | 0.00% | – |
Q2 2021 | $753,000 | -13.2% | 138,135 | +19.0% | 0.00% | – |
Q1 2021 | $868,000 | +45.4% | 116,098 | +111.0% | 0.00% | – |
Q4 2020 | $597,000 | – | 55,026 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 200,000 | $1,768,000 | 8.83% |
Samsara BioCapital, LLC | 1,407,949 | $11,608,000 | 3.24% |
Flagship Pioneering Inc. | 2,938,494 | $25,976,000 | 0.72% |
ARK Investment Management | 11,212,506 | $99,119,000 | 0.59% |
Portolan Capital Management | 450,861 | $3,986,000 | 0.45% |
Capital Impact Advisors, LLC | 168,600 | $1,490,000 | 0.44% |
Nikko Asset Management Americas, Inc. | 4,182,346 | $36,261,000 | 0.32% |
Sio Capital Management, LLC | 166,780 | $1,474,000 | 0.29% |
Virtus ETF Advisers LLC | 34,835 | $308,000 | 0.16% |
Artal Group S.A. | 465,500 | $4,115,000 | 0.10% |